nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy robert d guber , bs , varun takyar , md , angela kokkinis , bsn , rn , derrick a fox , md , hawwa alao , md , ilona kats , ba , dara bakar , ba , alan t remaley , md , phd , stephen m hewitt , md , phd , david e kleiner , md , phd , chia ying liu , phd , colleen hadigan , md , kenneth h fischbeck , md , yaron rotman , md and christopher grunseich , md correspondence to dr grunseich christopher grunseich at nih gov abstract objective to determine the prevalence and features of fatty liver disease in spinal and bulbar muscular atrophy sbma methods two groups of participants with sbma were evaluated in the first group , participants with sbma underwent laboratory analysis and liver imaging in the second group , participants with sbma were compared to female carriers and controls liver biopsies were done in participants with sbma results evidence of fatty liver disease was detected by magnetic resonance spectroscopy in all participants with sbma in the first group , with an average dome intrahepatic triacylglycerol of range , ref liver dome magnetic resonance spectroscopy measurements were significantly increased in participants with sbma in the second group relative to age and sex matched controls , with average disease and male control measurements of and , respectively liver biopsies were consistent with simple steatosis in participants and nonalcoholic steatohepatitis in others conclusions we observed evidence of nonalcoholic liver disease in nearly all of the participants with sbma evaluated these observations expand the phenotypic spectrum of the disease and provide a potential biomarker that can be monitored in future studies photo https www quora com what is liver failure